Literature DB >> 26349828

Intrinsic carbapenem-hydrolyzing oxacillinases from members of the genus Pandoraea.

Ines Schneider1, Adolf Bauernfeind2.   

Abstract

We analyzed the oxacillinases of isolates of six different species of Pandoraea, a genus that colonizes the respiratory tract of cystic fibrosis patients. The isolates produced carbapenem-hydrolyzing enzymes causing elevated MICs for amoxicillin, piperacillin, meropenem, and imipenem when expressed in an Escherichia coli host strain. Sequencing revealed nine new oxacillinases (OXA-151 to OXA-159) with a high degree of identity among isolates of the same species; however, they had much lower interspecies similarities. The intrinsic oxacillinase genes might therefore be helpful for correct identification of Pandoraea isolates.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26349828      PMCID: PMC4604371          DOI: 10.1128/AAC.01112-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

1.  Clinical and microbiological features of a cystic fibrosis patient chronically colonized with Pandoraea sputorum identified by combining 16S rRNA sequencing and matrix-assisted laser desorption ionization-time of flight mass spectrometry.

Authors:  A Fernández-Olmos; M I Morosini; A Lamas; M García-Castillo; L García-García; R Cantón; L Máiz
Journal:  J Clin Microbiol       Date:  2011-12-14       Impact factor: 5.948

2.  Development of a recA gene-based identification approach for the entire Burkholderia genus.

Authors:  George W Payne; Peter Vandamme; Sara H Morgan; John J Lipuma; Tom Coenye; Andrew J Weightman; T Hefin Jones; Eshwar Mahenthiralingam
Journal:  Appl Environ Microbiol       Date:  2005-07       Impact factor: 4.792

3.  Novel carbapenem-hydrolyzing oxacillinase OXA-62 from Pandoraea pnomenusa.

Authors:  Ines Schneider; Anne Marie Queenan; Adolf Bauernfeind
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

4.  Biochemical and genetic characterization of carbapenem-hydrolyzing β-lactamase OXA-229 from Acinetobacter bereziniae.

Authors:  Rémy A Bonnin; Alain A Ocampo-Sosa; Laurent Poirel; Hélène Guet-Revillet; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2012-04-16       Impact factor: 5.191

5.  Use of the gyrB gene for the identification of Pandoraea species.

Authors:  Tom Coenye; John J LiPuma
Journal:  FEMS Microbiol Lett       Date:  2002-02-19       Impact factor: 2.742

6.  Sepsis, multiple organ failure, and death due to Pandoraea pnomenusa infection after lung transplantation.

Authors:  Martin E Stryjewski; John J LiPuma; Robert H Messier; L Barth Reller; Barbara D Alexander
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

7.  Use of amplified ribosomal DNA restriction analysis for identification of Ralstonia and Pandoraea species: interest in determination of the respiratory bacterial flora in patients with cystic fibrosis.

Authors:  Christine Segonds; Sandrine Paute; Gérard Chabanon
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

8.  Pandoraea bacteremia in a cystic fibrosis patient with associated systemic illness.

Authors:  Lindsey N Johnson; Jin-Young Han; Samuel M Moskowitz; Jane L Burns; Xuan Qin; Janet A Englund
Journal:  Pediatr Infect Dis J       Date:  2004-09       Impact factor: 2.129

9.  Epidemic spread of Pandoraea apista, a new pathogen causing severe lung disease in cystic fibrosis patients.

Authors:  Inger Merete Jørgensen; Helle Krogh Johansen; Birgitte Frederiksen; Tacjana Pressler; Annelise Hansen; Peter Vandamme; Niels Høiby; Christian Koch
Journal:  Pediatr Pulmonol       Date:  2003-11

10.  "Stormy waters ahead": global emergence of carbapenemases.

Authors:  Gopi Patel; Robert A Bonomo
Journal:  Front Microbiol       Date:  2013-03-14       Impact factor: 5.640

View more
  7 in total

1.  Clinical and microbiological features of obstructive cholangitis with bloodstream infection caused by Pandoraea apista identified by MALDI-TOF mass spectrometry and ribosomal RNA sequencing in a cancer patient.

Authors:  Naoya Itoh; Nana Akazawa; Yuichi Ishibana; Toshiki Masuishi; Akinobu Nakata; Hiromi Murakami
Journal:  BMC Infect Dis       Date:  2022-06-07       Impact factor: 3.667

2.  Taxonomic position, antibiotic resistance and virulence factor production by Stenotrophomonas isolates from patients with cystic fibrosis and other chronic respiratory infections.

Authors:  Ad C Fluit; Jumamurat R Bayjanov; María Díez Aguilar; Rafael Cantón; Stuart Elborn; Michael M Tunney; Jelle Scharringa; Barry J Benaissa-Trouw; Miquel B Ekkelenkamp
Journal:  BMC Microbiol       Date:  2022-05-12       Impact factor: 4.465

3.  Pandoraea pnomenusa Isolated from an Australian Patient with Cystic Fibrosis.

Authors:  Mark Ambrose; Roslyn C Malley; Sanchia J C Warren; Sean A Beggs; Oliver F E Swallow; Belinda McEwan; David Stock; Louise F Roddam
Journal:  Front Microbiol       Date:  2016-05-11       Impact factor: 5.640

Review 4.  Pneumonia due to Pandoraea Apista after evacuation of traumatic intracranial hematomas:a case report and literature review.

Authors:  Chuanzhong Lin; Ning Luo; Qiang Xu; Jianjun Zhang; Mengting Cai; Guanhao Zheng; Ping Yang
Journal:  BMC Infect Dis       Date:  2019-10-22       Impact factor: 3.090

5.  Possible Prosthetic Valve Endocarditis by Pandoraea pnomenusa and Specific Virulence Mechanisms.

Authors:  Elias Bodendoerfer; Nicolas Personnic; Carlos A Mestres; Markus J Wilhelm; Lilly Meyer; Barbara Hasse
Journal:  Infect Drug Resist       Date:  2021-04-06       Impact factor: 4.003

6.  Meropenem-Resistant Pandoraea Pneumonia in a Critically Ill Patient With COVID-19.

Authors:  Mohammad M Dlewati; Pyi Phyo Aung; Kyeeun Park; Jose A Rodriguez; Kenneth K Poon
Journal:  Cureus       Date:  2021-11-12

7.  Genome insights from the identification of a novel Pandoraea sputorum isolate and its characteristics.

Authors:  Rui-Fang Gao; Ying Wang; Ying Wang; Zhi-Wen Wang; Gui-Ming Zhang
Journal:  PLoS One       Date:  2022-08-05       Impact factor: 3.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.